These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634 [TBL] [Abstract][Full Text] [Related]
3. G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. Hörnquist CE; Lu X; Rogers-Fani PM; Rudolph U; Shappell S; Birnbaumer L; Harriman GR J Immunol; 1997 Feb; 158(3):1068-77. PubMed ID: 9013944 [TBL] [Abstract][Full Text] [Related]
4. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009 [TBL] [Abstract][Full Text] [Related]
5. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331 [TBL] [Abstract][Full Text] [Related]
6. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820 [TBL] [Abstract][Full Text] [Related]
7. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms. Dignass AU; Baumgart DC; Sturm A Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888 [TBL] [Abstract][Full Text] [Related]
8. [Functional status of intestinal t lymphocytes, regulatory mechanisms, and their variations in the course of Crohn disease and ulcerative colitis]. Boirivant M; Marini M; Di Felice G Ann Ist Super Sanita; 1999; 35(2):283-9. PubMed ID: 10645662 [TBL] [Abstract][Full Text] [Related]
9. New mediators of immunity and inflammation in inflammatory bowel disease. Monteleone G; Fina D; Caruso R; Pallone F Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives. Neurath MF Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047 [TBL] [Abstract][Full Text] [Related]
12. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968 [TBL] [Abstract][Full Text] [Related]
13. The pathophysiologic rationale for biological therapies in inflammatory bowel disease. Gordon JN; Di Sabatino A; Macdonald TT Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease. Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633 [TBL] [Abstract][Full Text] [Related]
15. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells. Prehn JL; Landers CJ; Targan SR J Immunol; 1999 Oct; 163(8):4277-83. PubMed ID: 10510366 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T; May B; Pfisterer O; Müller KM; Brasch F Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933 [TBL] [Abstract][Full Text] [Related]
19. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis]. Rodrigues M; Zerbini MC; Barbieri D Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869 [TBL] [Abstract][Full Text] [Related]
20. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]